The Guilty Gilt Guide was written with a clear objective – to maximize the whole-herd performance of pig populations by helping gilts to reach their full reproductive potential and produce healthy pigs that reach their full genetic potential during grow-finish.
The open reading frames (ORF)5 represents approximately 4% of the porcine repro- ductive and respiratory syndrome virus (PRRSV)-2 genome (whole-PRRSV) and is often determined by the Sanger technique, which rarely detects >1 PRRSV strain if present in the sample.
Porcine reproductive and respiratory syndrome virus (PRRSV) is an important swine pathogen affecting the global swine industry.
Mycoplasma hyopneumoniae (M. hyopneumoniae) infections continue to result in significant respiratory challenges in the swine industry worldwide. Vaccination for M. hyopneumoniae is commonly utilized, as reduction in bacterial loads and clinical severity in vaccinated pigs have been shown. However, the effect of M. hyopneumoniae vaccination on transmission across different pig populations has been minimally investigated.
Don’t miss any news on PRRS disease control Subscribe now to PRRS.com newsletter
Strategic use of PRRS MLV, herd closure, and flow management in a 26000-sow production system to improve the reproductive and growing pig performance.
A significant improvement in reproductive and growing pig performance was achieved by a well-defined process that included the strategic use of Ingelvac PRRS MLV.
Wean to finish site with pigs coming from four to 11 different sow herds in Canada, and varying PRRS status.
Ingelvac PRRS MLV was used at the day of pig arrival to stabilize the pig population.
Ongoing improvement in the operation was observed with the PRRS management program.
Two-hundred sow farm (farrow to finish) located in South Korea.
PRSSV horizontal transmission occurred post-weaning with apparent clinical manifestation of disease.
Implementation of a PRRSV MLV vaccination program in piglets controlled PRRSV infection and reduced clinical signs and mortality.
The objective of this report was to summarize experimental data on PRRSV MLV efficacy following challenge with genetically diverse PRRSV field isolates.
Use of a modified-live PRRSV vaccine significantly reduced lung lesions in multiple challenge models.